1201903-03-8

Basic information

• Product Name: N,N',N"-[boroxin-2,4,6-triyltris[[(1R)-3-methylbutane-1,1-diyl]imino(2-oxoethane-2,1-diyl)] ]tris(2,5-dichlorobenzamide)
• Synonyms: N,N',N"-[boroxin-2,4,6-triyltris[[(1R)-3-methylbutane-1,1-diyl]imino(2-oxoethane-2,1-diyl)] ]tris(2,5-dichlorobenzamide)
• CAS NO: 1201903-03-8
• Molecular Formula: C₄₂H₅₁B₃Cl₆N₆O₉
• Molecular Weight: 1029.04
• Mol File: 1201903-03-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N,N',N"-[boroxin-2,4,6-triyltris[[(1R)-3-methylbutane-1,1-diyl]imino(2-oxoethane-2,1-diyl)] ]tris(2,5-dichlorobenzamide)(CAS DataBase Reference)
• NIST Chemistry Reference: N,N',N"-[boroxin-2,4,6-triyltris[[(1R)-3-methylbutane-1,1-diyl]imino(2-oxoethane-2,1-diyl)] ]tris(2,5-dichlorobenzamide)(1201903-03-8)
• EPA Substance Registry System: N,N',N"-[boroxin-2,4,6-triyltris[[(1R)-3-methylbutane-1,1-diyl]imino(2-oxoethane-2,1-diyl)] ]tris(2,5-dichlorobenzamide)(1201903-03-8)

Safety Data

• Hazardous Substances Data: 1201903-03-8(Hazardous Substances Data)

Upstream product

• 1201903-02-7 2,5-dichloro-N-[2-({(1R)-3-methyl-1-[(3aS,4S,6S,7aR)-3a,5,5-trimethylhexa-hydro-2H-4,6-methano-1,3,2-benzodioxaborol-2-yl]butyl}amino)-2-oxoethyl]benzamide 

Downstream Products

• 1201902-84-2 2,5-dichloro-N-(2-([(1R)-1-(4,4-dimethyl-5-oxo-1,3,2-dioxaborolan-2-yl)-3-methylbutyl]amino)-2-oxoethyl)benzamide 
• 1201902-85-3 2-chloro-5-chloro-N-[2-({(1R)-3-methyl-1-[(5R)-4-oxo-5-phenyl-1,3,2-dioxaborolan-2-yl]butyl}amino)-2-oxoethyl]benzamide 
• 1201902-86-4 2,5-dichloro-N-[2-({(1R)-3-methyl-1-[(4S)-4-methyl-5-oxo-1,3,2-dioxaborolan-2-yl]butyl}amino)-2-oxoethyl]benzamide 
• 1201902-80-8 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid 
• 1201902-92-2 ixazomib salicylate 
• 1201902-88-6 2,5-dichloro-N-(2-{[(1R)-1-(4,4-dimethyl-6-oxo-1,3,2-dioxaborinan-2-yl)-3-methylbutyl]amino}-2-oxoethyl)benzamide 
• 1201902-93-3 2,5-dichloro-N-(2-{[(1R)-3-methyl-1-(5-oxo-4,4-diphenyl-1,3,2-dioxaborolan-2-yl)butyl]amino}-2-oxoethyl)benzamide 
• 1239908-20-3 2,2’-{2-[(1R)-1-({[(2,5-dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid 

Relevant articles and documents

BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF

The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.